Knowledge, attitude, and practice outcomes: Evaluating the impact of counseling in hospitalized diabetic patients in India

P and T

Volumn 31, Issue 7, 2006, Pages 383-392

  Palaian, Subish ^a,b   Acharya, Leelavathy D ^a   Rao, Padma Guru Madhva ^a   Shankar, P Ravi ^b   Nair, Nidin Mohan ^a   Nair, Nibu P ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

^b MANIPAL TEACHING HOSPITAL   (Nepal)

Author keywords

Diabetes; Knowledge, attitude, and practice outcomes; Patient counseling

Indexed keywords

ACARBOSE; GLIBENCLAMIDE; GLUCOSE; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CHRONIC DISEASE; DIABETES MELLITUS; DIET; DRUG INFORMATION; EXERCISE; FEMALE; FOLLOW UP; HOSPITAL PATIENT; HUMAN; HYPOGLYCEMIA; INDIA; KNOWLEDGE; LANGUAGE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT COUNSELING; PHARMACIST;

EID: 33746633308     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Anderson-Harper HM, Berger BA, Noel R. Pharmacists' predisposition to communicate, desire to counsel, and job satisfaction. Am J Pharm Educ 1992;56:252-258.
2. Pharmacy communication. In: Hassan WE, ed. Hospital Pharmacy, 5th ed. Philadelphia: Lea & Febiger, 1986:154-159.
3. Popovich NG. Ambulatory patient care. In: Gennaro AR, ed. Remington: The Science and Practice of Pharmacy, 19th ed. Easton, PA: Mack Publishing; 1995:1695-1719.
4. Jepson MH. Patient compliance and counseling. In: Collet DM, Aulton ME, eds. Pharmaceutical Practice. Edinburgh: Churchill Livingstone; 1990:346-349.
5. Dooley M, Lyall H, Galbriath K, et al. SHPA standards of practice for clinical pharmacy. In: Society of Hospital Pharmacists of Australia (SHPA). Practice Standards and Definitions, 1996:2-11.
6. Omnibus Budget Reconciliation Act of 1990, Pub. L. No. 101-508, and 4401, 104 stat 1388, 1990.
7. American Society of Hospital Pharmacists. ASHP guidelines on pharmacist-conducted patient counseling. Am J Hosp Pharm 1976; 33:644-645.
8. American Diabetes Association. Diabetes statistics. Available at: www.diabetes.org/diabetes-statistics.jsp. Accessed June 29, 2006.
9. Kapur A, Shishoo S, Ahuja MMS. Diabetes care in India: Physicians' perceptions attitudes and practices (DIAPP-2 study). Int J Diabetes Dev Countries 1998;18:124-130.
10. Cantrill JA, Wood J. Diabetes mellitus. In: Walker R, Edwards CRW, eds. Clinical Pharmacy and Therapeutics, 3rd ed. Edinburgh: Churchill Livingstone; 1999:657-677.
11. Coons SJ. Health outcomes and quality of life. In: DiPiro JT, Talbert RL, Yee GC, eds. Pharmacotherapy: A Pathophysiological Approach, 4th ed. Norwalk, CT: Appleton & Lange; 1999:12-20.
12. American Diabetes Association. Diabetes mellitus and exercise. Diabetes Care 1997;20:1908-1912.
13. The Diabetes Control and Complications (DCCT) Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
14. United Kingdom Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998;352:837-853.
15. Jaber LA, Halapy H, Fernet M, et al. Evaluation of pharmaceutical care model on diabetes management. Ann Pharmacother 1996;30; 238-242.
16. Rasheed A, Ramesh A, Nagavi BG. Improvement in quality of life through patient counseling. Pharma Times 2002;34:9-10,14.
17. Lewis RK, Lasack NL, Lambert BL, et al. Patient counseling: A focus on maintenance therapy. Am J Health Syst Pharm 1997;54: 2084-2095.
18. Setter SM, White JR, Campbell RK. Diabetes. In: Herfindal ET, Gourley DR, eds. Textbook of Therapeutics: Drug and Disease Management, 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2000:377-406.
19. National Asthma Education Program Coordinating Committee. Expert Panel on the Management of Asthma: Patient education. J Allergy Clin Immunol 1991;88:460-472.
20. Hawkins DW, Fiedler FP, Dougles HL, Eschbach RC. Evaluation of a clinical pharmacist in caring for hypertensive and diabetic patients. Am J Hosp Pharm 1979;36:1321-1325.
21. Oki JC, Isley WL. Diabetes mellitus. In: DiPiro JT, Talbert RL, Yee GC, eds. Pharmacotherapy: A Pathophysiological Approach, 5th ed. Stamford, CT: Appleton & Lange; 2002;1335-1358.
22. Schilling KW. Pharmacy program for monitoring diabetic patients. Am J Hosp Pharm 1977;34:1242-1245.
23. Sczupak CA, Conrad WF. Relationship between patient-oriented pharmaceutical services and therapeutic outcomes of ambulatory patients with diabetes mellitus. Am J Hosp Pharm 1977;34: 1238-1242.
24. Kaeter AJ, Ferrara A, Darbinian JA, et al. Self-monitoring of diabetes. Diabetes Care 2000;23:477-483.
25. Sivagnanam G, Namasivayam K, Rajasekaran M, et al. A comparative study of the knowledge, beliefs, and practices of diabetic patients cared for at a teaching hospital (free service) and those cared for by private practitioners (paid service). Ann NY Acad Sci 2002;958:416-419.
26. Raisch DW. Barriers to providing cognitive services. Am Pharm 1993;33:54-58.